Illustrative image – not actual.Glenmark Pharmaceuticals has approved a proposal to raise up to USD 200 million (about Rs 1,413 crore) through issuance of debt securities.
The company plans to raise the money in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches.
The price at which the debt securities will be issued will be determined by the board in accordance with applicable laws and consultation with appropriate advisors.
